InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,621.60
(
0.46%
)
US TECH 100
18,983.68
(
0.29%
)
Dow Jones
41,385.01
(
0.70%
)
Brent Oil
71.75
(
-0.31%
)
Bitcoin
59,410.72
(
2.19%
)
Post# of 253109
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sks144

Send PM Follow Ignore
Followers 1
Posts 9
Boards Moderated 0
Alias Born 02/15/2023

sks144

Re: iwfal post# 245495

Wednesday, 02/15/2023 12:46:12 PM

Wednesday, February 15, 2023 12:46:12 PM

Post# of 253109
The HR and P values in their P2 TNBC trial were encouraging. Maybe the real value of Trila isn’t in Myeloprotection but in anti tumor efficacy in immunologically hot tumor types. Clearly CRC was a mistake- but the drug did what it was supposed to do on the primary- it must have had some negative interaction with the chemo however
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up